Home All Tags due diligence in pharma Compliance Risks

Novartis bribery allegations highlight compliance risks in pharma
Posted on 05-23-2017 by Ulyana Androsova

Recent allegations that Novartis bribed doctors in Greece serve as a reminder that the pharmaceutical industry has a high risk of bribery and corruption. We look at the reasons behind the risk, and how companies can enhance compliance risk mitigation. New markets for pharma increase bribery and corruption... Read More

Pharma Industry Faces Rough Seas When it Comes to Compliance Risk
Posted on 01-14-2016 by Ulyana Androsova

Would you set sail with your family without reassuring yourself that the boat is well-equipped to reach your destination safely? Probably not. Yet, time and again, we see proof that companies voyage into the global business operations with a limited view of potential compliance threats. In recent years... Read More